Blood Banking Market - Global Forecast 2025-2032

The blood banking market is evolving rapidly, driven by technological innovation, regulatory change, and growing demand for resilient healthcare solutions. Senior leaders need clear, current intelligence to navigate this complex landscape and identify competitive opportunities.

Market Snapshot: Blood Banking Market Size and Growth

The blood banking market grew from USD 16.89 billion in 2024 to USD 19.15 billion in 2025. With projected growth at a CAGR of 13.43%, the sector is anticipated to reach USD 46.31 billion by 2032. This expansion reflects increased adoption of automation, innovative safety technologies, and robust demand for efficient supply chain solutions across health systems and markets worldwide.

Scope & Segmentation of the Blood Banking Market

This report provides a comprehensive analysis of the entire blood banking ecosystem, offering deep segmentation and actionable insights for decision-makers.

• Product Type: Cryoprecipitate, plasma, platelets, red blood cells, and whole blood are examined for their processing protocols, clinical applications, and role in supporting healthcare interventions.
• Application: Diagnostics, research, and transfusion uses are reviewed in detail, highlighting each application’s contribution to patient outcomes and healthcare system effectiveness.
• End User: The report evaluates ambulatory surgical centers, blood banks, as well as hospitals and clinics, with attention to specific service models and operational priorities.
• Testing Type: Blood grouping testing and infectious disease testing are analyzed, focusing on safety protocols and advancements to ensure compatibility and minimize transmission risk.
• Collection Method: Both apheresis collection and whole blood collection are covered to showcase flexibility and efficiency in meeting transfusion requirements.
• Donor Type: Family replacement donors, paid donors, and voluntary donors are segmented to provide insight into recruitment dynamics, outreach challenges, and motivational strategies.
• Regional Coverage: Americas (with sub-regions including the United States, Canada, Mexico, and others), Europe, Middle East & Africa (covering major economies and healthcare markets), and Asia-Pacific (from China and India to Southeast Asia) are all covered to reflect unique challenges and growth drivers.
• Key Players: The report tracks significant developments across companies such as Haemonetics Corporation, Grifols, S.A., Terumo Corporation, Fresenius Kabi AG, Macopharma SA, Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, Immucor, Inc., Cerus Corporation, and Hologic, Inc.

Key Takeaways Shaping the Blood Banking Market

• Modern blood banking systems are integral for healthcare system resilience, with a focus on process integrity, donor mobilization, and advanced safety protocols.
• Automation and data-driven platforms are reducing manual errors and supporting predictive inventory management, enabling agile responses to fluctuating demand.
• Digital engagement—including mobile apps and targeted campaigns—is elevating donor retention, while interoperability of data systems is improving traceability and compliance.
• Operational excellence requires navigating technological, logistical, and regulatory complexities, especially as emerging economies invest in capacity-building and regional harmonization.
• Strategic partnerships, joint ventures, and localized manufacturing are giving industry leaders the ability to respond to shifting market and compliance requirements with greater flexibility.
• Segmentation by product, donor type, collection method, and region yields opportunities for targeted offerings, stakeholder engagement, and operational differentiation.

Tariff Impact: United States Policy Changes

Recent changes to U.S. tariff schedules have reshaped procurement and supply chain strategies industry-wide. Increased duties on imports such as laboratory reagents, diagnostic kits, and specialized equipment are raising costs and spurring interest in domestic sourcing and regional partnerships. Many providers are now accelerating investments in local manufacturing, dual sourcing, and collaborative forecasting to maintain cost-effective and reliable access to critical consumables.

Methodology & Data Sources

This report draws from peer-reviewed literature, government reports, and industry white papers, alongside primary interviews with laboratory managers, clinicians, and procurement professionals. Data was triangulated and verified through expert panels and validation protocols to deliver reliable and comprehensive market analysis.

Why This Report Matters

• Enables leaders to benchmark current operations and future strategies against industry best practices and emerging trends.
• Supports risk mitigation and growth by providing detailed analysis of policy, supply chain, segment, and regional dynamics relevant to executive decision-making.
• Facilitates opportunity identification across the blood banking value chain, aiding in investment, partnership, and operational optimization decisions.

Conclusion

The blood banking market is undergoing transformative change. Leveraging research-driven intelligence positions stakeholders to navigate risks, capture growth potential, and enhance patient care outcomes across global healthcare environments.